SKP2 (S-phase kinase associated protein 2)

2003-02-01  

Identity

HGNC
LOCATION
5p13.2
LOCUSID
ALIAS
FBL1,FBXL1,FLB1,p45
FUSION GENES

Other Information

Locus ID:

NCBI: 6502
MIM: 601436
HGNC: 10901
Ensembl: ENSG00000145604

Variants:

dbSNP: 6502
ClinVar: 6502
TCGA: ENSG00000145604
COSMIC: SKP2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000145604ENST00000274254Q13309
ENSG00000145604ENST00000274255Q13309
ENSG00000145604ENST00000274255A0A024R069
ENSG00000145604ENST00000504386H0Y9I9
ENSG00000145604ENST00000508514D6RAG5
ENSG00000145604ENST00000509692D6RF40
ENSG00000145604ENST00000513151D6R9R7
ENSG00000145604ENST00000513263D6RF40
ENSG00000145604ENST00000546211A0A0A0MTL5
ENSG00000145604ENST00000620197Q13309

Expression (GTEx)

0
5
10
15
20
25
30
35

Pathways

PathwaySourceExternal ID
Cell cycleKEGGko04110
Ubiquitin mediated proteolysisKEGGko04120
mTOR signaling pathwayKEGGko04150
Small cell lung cancerKEGGko05222
Cell cycleKEGGhsa04110
Ubiquitin mediated proteolysisKEGGhsa04120
mTOR signaling pathwayKEGGhsa04150
Pathways in cancerKEGGhsa05200
Small cell lung cancerKEGGhsa05222
Herpes simplex infectionKEGGko05168
Herpes simplex infectionKEGGhsa05168
SCF-SKP2 complexKEGGhsa_M00381
Epstein-Barr virus infectionKEGGhsa05169
Epstein-Barr virus infectionKEGGko05169
Viral carcinogenesisKEGGhsa05203
Viral carcinogenesisKEGGko05203
SCF-SKP2 complexKEGGM00381
FoxO signaling pathwayKEGGhsa04068
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Class I MHC mediated antigen processing & presentationREACTOMER-HSA-983169
Antigen processing: Ubiquitination & Proteasome degradationREACTOMER-HSA-983168
Cell CycleREACTOMER-HSA-1640170
Cell Cycle, MitoticREACTOMER-HSA-69278
Mitotic G1-G1/S phasesREACTOMER-HSA-453279
G1 PhaseREACTOMER-HSA-69236
Cyclin D associated events in G1REACTOMER-HSA-69231
G1/S TransitionREACTOMER-HSA-69206
Cyclin E associated events during G1/S transitionREACTOMER-HSA-69202
SCF(Skp2)-mediated degradation of p27/p21REACTOMER-HSA-187577
S PhaseREACTOMER-HSA-69242
Cyclin A:Cdk2-associated events at S phase entryREACTOMER-HSA-69656
Regulation of mitotic cell cycleREACTOMER-HSA-453276
APC/C-mediated degradation of cell cycle proteinsREACTOMER-HSA-174143
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1REACTOMER-HSA-174178
DeubiquitinationREACTOMER-HSA-5688426
Ub-specific processing proteasesREACTOMER-HSA-5689880

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
378508852024A critical role of the endothelial S-phase kinase-associated protein 2/phosphatase and tensin homologue axis in angiogenesis and psoriasis.0
378719112024SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.3
381842732024Skp2: A critical molecule for ubiquitination and its role in cancer.0
383558072024Targeted inhibition of SCF(SKP2) confers anti-tumor activities resulting in a survival benefit in osteosarcoma.1
383962922024O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.0
385613752024Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.0
378508852024A critical role of the endothelial S-phase kinase-associated protein 2/phosphatase and tensin homologue axis in angiogenesis and psoriasis.0
378719112024SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.3
381842732024Skp2: A critical molecule for ubiquitination and its role in cancer.0
383558072024Targeted inhibition of SCF(SKP2) confers anti-tumor activities resulting in a survival benefit in osteosarcoma.1
383962922024O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.0
385613752024Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.0
366949142023SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.5
367978282023LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.1
372577692023Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma.1

Citation

Dessen P

SKP2 (S-phase kinase associated protein 2)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42307/cancer-prone-explorer/favicon/welcome